Short-term survivorship of antioxidant highly cross-linked polyethylene liners in total hip arthroplasty reported in American Joint Replacement Registry

Table 2 Revision rate and reason for revision rates for Novation, Alteon, and aggregate antioxidant groups, n (%)

Revisions	Novation (n = 461)	Alteon (n = 989)	Aggregate antioxidant (n = 39964)	Novation vs aggregate, P value	Alteon vs aggregate, P value
All-cause	4 (0.87)	18 (1.82)	986 (2.47)	0.02	0.23
Fracture (including periprosthetic fracture)	2 (0.43)	6 (0.61)	247 (0.62)	0.99	0.99
Infection	0 (0.00)	6 (0.61)	205 (0.51)	0.18	0.86
Aseptic loosening	0 (0.00)	2 (0.20)	116 (0.29)	0.65	0.99
Instability	0 (0.00)	3 (0.30)	248 (0.62)	0.12	0.30
Mechanical complications	0 (0.00)	2 (0.20)	101 (0.25)	0.63	0.33
Hematoma or wound complications	0 (0.00)	1 (0.10)	24 (0.06)	0.99	0.46
Wear	0 (0.00)	0 (0.00)	3 (0.01)	0.99	0.99
Pain	0 (0.00)	2 (0.20)	80 (0.20)	0.99	0.99
Revisions for all other reasons	2 (0.43)	1 (0.10)	229 (0.57)	0.19	0.05

F¹ “Other” reasons include non-specific or possibly irrelevant/erroneous diagnoses including cardiac conditions, hypertension, obesity, etc.